Abbott Diagnostics has developed a panel of congenital assays for its popular Architect platform. These assays can be used for the detection of human cytomegalovirus (CMV), Toxoplasma gondii and rubella virus.
While other avidity assays remove low-avidity antibodies by washing, the new Architect AVIcomp technology removes the high-avidity antibodies selectively and detects low-avidity antibodies directly for improved diagnosis of acute or recurrent infection.
www.abbottdiagnostics.co.uk